top of page

SPECIALTY
Quetiapine
Sustained Release Tablet 50 mg & 200 mg
Indication
1. Treatment of schizophrenia.
2. Acute treatment of manic or mixed episodes associated with bipolar I disorder, both as monotherapy and as an adjunct to lithium or divalproex.
3. Acute treatment of depressive episodes associated with bipolar disorder.
4. Maintenance treatment of bipolar I disorder, as an adjunct ot lithium or divalproex
5. Adjunctive therapy ot antidepressants for the treatment of Major Depressive Disorder (MDD)
bottom of page